After the US Food and Drug Administration (FDA) expanded emergency authorisation for Pfizer’s COVID-19 vaccination booster on May 17, Americans as young as 5 can acquire it. The FDA approved a third Pfizer injection for youngsters aged 5 to 11 who had had their second dosage at least five months before. The second injection is required due to diminishing protection from the original series of two doses, according to Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research. The decision was met with some backlash. Dr. Monica Gandhi, an infectious disease expert at the University of California, San Francisco, told The Epoch Times via email, “There is no evidence that children 5-11 years old require a booster injection of the vaccine, nor of shown benefit.” Pfizer’s decision is based on data from just 67 youngsters who … Continue reading FDA Approved Pfizer Booster For Children As Young As 5.